Centrient Pharmaceuticals Overview
- Year Founded
-
1868
- Status
-
Private
- Employees
-
1,800
- Latest Deal Type
-
Debt Refin.
- Financing Rounds
-
6
- Investments
-
1
Centrient Pharmaceuticals General Information
Description
Manufacturer of sustainable antibiotics, next-generation statins and antifungals intended to fight against antimicrobial resistance. The company specializes in the production and commercialization of sustainable antibiotics and intermediates, active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs), enabling its clients to meet their sustainable and accessible pharmaceutical needs effectively.
Contact Information
Website
www.centrient.comCorporate Office
- Weena 798 E-F
- 3014 DA Rotterdam
- Netherlands
Corporate Office
- Weena 798 E-F
- 3014 DA Rotterdam
- Netherlands
Centrient Pharmaceuticals Timeline
Centrient Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Centrient Pharmaceuticals Comparisons
Industry
Financing
Details
Centrient Pharmaceuticals Competitors (9)
One of Centrient Pharmaceuticals’s 9 competitors is Sayre Therapeutics, a Formerly VC-backed company based in Bangalore, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sayre Therapeutics | Formerly VC-backed | Bangalore, India | ||||
| MSN Laboratories | Private Debt Financed | Hyderabad, India | ||||
| Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
| Paratek Pharmaceuticals | Private Equity-Backed | King of Prussia, PA |
Centrient Pharmaceuticals Patents
Centrient Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026195815-A1 | Process for producing compounds free of nitrosamine impurities | Pending | 20-Mar-2025 | ||
| WO-2026195818-A1 | Process for producing sitagliptin free of nitrosamine impurities | Pending | 20-Mar-2025 | ||
| WO-2025052002-A1 | Method for hydroxylation of bile acids or analogues thereof | Inactive | 08-Sep-2023 | ||
| WO-2021094458-A1 | Novel broad range beta-lactamases | Inactive | 12-Nov-2019 | ||
| EP-3430153-A1 | Mbth-like proteins in eukaryotic nrps-catalyzed processes | Inactive | 14-Apr-2016 | C07K14/195 |
Centrient Pharmaceuticals Signals
Centrient Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Centrient Pharmaceuticals Investments (1)
Centrient Pharmaceuticals’s most recent deal was a Buyout/LBO with Astral SteriTech. The deal was made on 31-Aug-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Astral SteriTech | 31-Aug-2021 | Buyout/LBO | Drug Delivery |
Centrient Pharmaceuticals FAQs
-
When was Centrient Pharmaceuticals founded?
Centrient Pharmaceuticals was founded in 1868.
-
Where is Centrient Pharmaceuticals headquartered?
Centrient Pharmaceuticals is headquartered in Rotterdam, Netherlands.
-
What is the size of Centrient Pharmaceuticals?
Centrient Pharmaceuticals has 1,800 total employees.
-
What industry is Centrient Pharmaceuticals in?
Centrient Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Centrient Pharmaceuticals a private or public company?
Centrient Pharmaceuticals is a Private company.
-
What is Centrient Pharmaceuticals’s current revenue?
The current revenue for Centrient Pharmaceuticals is .
-
How much funding has Centrient Pharmaceuticals raised over time?
Centrient Pharmaceuticals has raised $1B.
-
Who are Centrient Pharmaceuticals’s investors?
Bain Capital, Ergo Partners, and Planet B.io have invested in Centrient Pharmaceuticals.
-
Who are Centrient Pharmaceuticals’s competitors?
Sayre Therapeutics, MSN Laboratories, Glenmark Pharmaceuticals, Intas Pharmaceuticals, and Paratek Pharmaceuticals are some of the 9 competitors of Centrient Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process